Background: Chronic granulomatous disease (CGD) is an inherited defect in phagocytic respiratory burst that results in severe and life-threatening infections in affected children. Single center studies from India have shown that proportion of autosomal recessive (AR) CGD is more than that reported from the West. Further, affected patients have high mortality rates due to late referrals and difficulties in accessing appropriate treatment. However, there is lack of multicentric collaborative data on CGD from India. Objective: To describe infection patterns, immunological, and molecular features of CGD from multiple centers in India. Methods: A detailed proforma that included clinical and laboratory details was prepared and sent to multiple centers in India that are involved in the care and management of patients with inborn errors of immunity. Twelve centers have provided data which were later pooled together and analyzed. Results: Of the 236 patients analyzed in our study, X-linked and AR-CGD was seen in 77 and 97, respectively. Male female ratio was 172:64. Median age at onset of symptoms and diagnosis was 8 and 24 months, respectively. Common infections documented include pneumonia (71.6%), lymphadenitis (31.6%), skin and subcutaneous abscess (23.7%), blood-stream infection (13.6%), osteomyelitis (8.6%), liver abscess (7.2%), lung abscess (2.9%), meningoencephalitis (2.5%), splenic abscess (1.7%), and brain abscess (0.9%). Forty-four patients (18.6%) had evidence of mycobacterial infection. Results of molecular assay were available for 141 patients (59.7%)-CYBB (44.7%) gene defect was most common, followed by NCF1 (31.9%), NCF2 (14.9%), and CYBA (8.5%). While CYBA variants were documented only in Southern and Western parts of India, a common dinucleotide deletion in NCF2 (c.835_836delAC) was noted only in North Indian population. Of the 174 patients with available outcome data, 67 (38.5%) had expired. Hematopoietic stem cell transplantation was carried out in 23 patients, and 12 are doing well on follow-up. Conclusions: In India, proportion of patients with AR-CGD is higher as compared to Western cohorts, though regional differences in types of AR-CGD exist. Clinical profile and mortality rates are similar in both X-linked and AR-CGD. However, this may be a reflection of the fact that milder forms of AR-CGD are probably being missed.
Background: Chronic granulomatous disease (CGD) is an inherited defect in phagocytic respiratory burst that results in severe and life-threatening infections in affected children. Single center studies from India have shown that proportion of autosomal recessive (AR) CGD is more than that reported from the West. Further, affected patients have high mortality rates due to late referrals and difficulties in accessing appropriate treatment. However, there is lack of multicentric collaborative data on CGD from India. Objective: To describe infection patterns, immunological, and molecular features of CGD from multiple centers in India. Methods: A detailed proforma that included clinical and laboratory details was prepared and sent to multiple centers in India that are involved in the care and management of patients with inborn errors of immunity. Twelve centers have provided data which were later pooled together and analyzed. Results: Of the 236 patients analyzed in our study, X-linked and AR-CGD was seen in 77 and 97, respectively. Male female ratio was 172:64. Median age at onset of symptoms and diagnosis was 8 and 24 months, respectively. Common infections documented include pneumonia (71.6%), lymphadenitis (31.6%), skin and subcutaneous abscess (23.7%), blood-stream infection (13.6%), osteomyelitis (8.6%), liver abscess (7.2%), lung abscess (2.9%), meningoencephalitis (2.5%), splenic abscess (1.7%), and brain abscess (0.9%). Forty-four patients (18.6%) had evidence of mycobacterial infection. Results of molecular assay were available for 141 patients (59.7%)-CYBB (44.7%) gene defect was most common, followed by NCF1 (31.9%), NCF2 (14.9%), and CYBA (8.5%). While CYBA variants were documented only in Southern and Western parts of India, a common dinucleotide deletion in NCF2 (c.835_836delAC) was noted only in North Indian population. Of the 174 patients with available outcome data, 67 (38.5%) had expired. Hematopoietic stem cell transplantation was carried out in 23 patients, and 12 are doing well on follow-up. Conclusions: In India, proportion of patients with AR-CGD is higher as compared to Western cohorts, though regional differences in types of AR-CGD exist. Clinical profile and mortality rates are similar in both X-linked and AR-CGD. However, this may be a reflection of the fact that milder forms of AR-CGD are probably being missed.
Authors: Chaim O Jacob; Miriam Eisenstein; Mary C Dinauer; Wenyu Ming; Qiang Liu; Sutha John; Francesco P Quismorio; Andreas Reiff; Barry L Myones; Kenneth M Kaufman; Deborah McCurdy; John B Harley; Earl Silverman; Robert P Kimberly; Timothy J Vyse; Patrick M Gaffney; Kathy L Moser; Marisa Klein-Gitelman; Linda Wagner-Weiner; Carl D Langefeld; Don L Armstrong; Raphael Zidovetzki Journal: Proc Natl Acad Sci U S A Date: 2011-12-27 Impact factor: 11.205
Authors: Baruch Wolach; Ronit Gavrieli; Martin de Boer; Karin van Leeuwen; Sivan Berger-Achituv; Tal Stauber; Josef Ben Ari; Menachem Rottem; Yechiel Schlesinger; Galia Grisaru-Soen; Omar Abuzaitoun; Nufar Marcus; Ben Zion Garty; Arnon Broides; Jakov Levy; Polina Stepansky; Amos Etzioni; Raz Somech; Dirk Roos Journal: Am J Hematol Date: 2016-11-18 Impact factor: 10.047
Authors: Beatriz E Marciano; Sergio D Rosenzweig; David E Kleiner; Victoria L Anderson; Dirk N Darnell; Sandra Anaya-O'Brien; Dianne M Hilligoss; Harry L Malech; John I Gallin; Steven M Holland Journal: Pediatrics Date: 2004-08 Impact factor: 7.124
Authors: Annemarie van de Geer; Alejandro Nieto-Patlán; Douglas B Kuhns; Anton Tj Tool; Andrés A Arias; Matthieu Bouaziz; Martin de Boer; José Luis Franco; Roel P Gazendam; John L van Hamme; Michel van Houdt; Karin van Leeuwen; Paul Jh Verkuijlen; Timo K van den Berg; Juan F Alzate; Carlos A Arango-Franco; Vritika Batura; Andrea R Bernasconi; Barbara Boardman; Claire Booth; Siobhan O Burns; Felipe Cabarcas; Nadine Cerf Bensussan; Fabienne Charbit-Henrion; Anniek Corveleyn; Caroline Deswarte; María Esnaola Azcoiti; Dirk Foell; John I Gallin; Carlos Garcés; Margarida Guedes; Claas H Hinze; Steven M Holland; Stephen M Hughes; Patricio Ibañez; Harry L Malech; Isabelle Meyts; Marcela Moncada-Velez; Kunihiko Moriya; Esmeralda Neves; Matias Oleastro; Laura Perez; Vimel Rattina; Carmen Oleaga-Quintas; Neil Warner; Aleixo M Muise; Jeanet Serafín López; Eunice Trindade; Julia Vasconcelos; Séverine Vermeire; Helmut Wittkowski; Austen Worth; Laurent Abel; Mary C Dinauer; Peter D Arkwright; Dirk Roos; Jean-Laurent Casanova; Taco W Kuijpers; Jacinta Bustamante Journal: J Clin Invest Date: 2018-08-06 Impact factor: 14.808
Authors: Xiao Chen; Dongdong Wang; Jianger Lan; Guangfei Wang; Lin Zhu; Xiaoyong Xu; Xiaowen Zhai; Hong Xu; Zhiping Li Journal: Ann Transl Med Date: 2021-09
Authors: Bárbara C S Reis; Daniela P Cunha; Ana Paula S Bueno; Flavia A A Carvalho; Juliana Dutra; Fabiana V Mello; Maria Cecília Menks Ribeiro; Cristiane B Milito; Elaine Sobral da Costa; Zilton Vasconcelos Journal: Genes (Basel) Date: 2021-09-23 Impact factor: 4.096
Authors: Koon-Wing Chan; Chung-Yin Wong; Daniel Leung; Xingtian Yang; Susanna F S Fok; Priscilla H S Mak; Lei Yao; Wen Ma; Huawei Mao; Xiaodong Zhao; Weiling Liang; Surjit Singh; Mohamed-Ridha Barbouche; Jian-Xin He; Li-Ping Jiang; Woei-Kang Liew; Minh Huong Thi Le; Dina Muktiarti; Fatima Johanna Santos-Ocampo; Reda Djidjik; Brahim Belaid; Intan Hakimah Ismail; Amir Hamzah Abdul Latiff; Way Seah Lee; Tong-Xin Chen; Jinrong Liu; Runming Jin; Xiaochuan Wang; Yin Hsiu Chien; Hsin-Hui Yu; Dinesh Raj; Revathi Raj; Jenifer Vaughan; Michael Urban; Sylvia van den Berg; Brian Eley; Anselm Chi-Wai Lee; Mas Suhaila Isa; Elizabeth Y Ang; Bee Wah Lee; Allen Eng Juh Yeoh; Lynette P Shek; Nguyen Ngoc Quynh Le; Van Anh Thi Nguyen; Anh Phan Nguyen Lien; Regina D Capulong; Joanne Michelle Mallillin; Jose Carlo Miguel M Villanueva; Karol Anne B Camonayan; Michelle De Vera; Roxanne J Casis-Hao; Rommel Crisenio M Lobo; Ruby Foronda; Vicky Wee Eng Binas; Soraya Boushaki; Nadia Kechout; Gun Phongsamart; Siriporn Wongwaree; Chamnanrua Jiratchaya; Mongkol Lao-Araya; Muthita Trakultivakorn; Narissara Suratannon; Orathai Jirapongsananuruk; Teerapol Chantveerawong; Wasu Kamchaisatian; Lee Lee Chan; Mia Tuang Koh; Ke Juin Wong; Siew Moy Fong; Meow-Keong Thong; Zarina Abdul Latiff; Lokman Mohd Noh; Rajiva de Silva; Zineb Jouhadi; Khulood Al-Saad; Pandiarajan Vignesh; Ankur Kumar Jindal; Amit Rawat; Anju Gupta; Deepti Suri; Jing Yang; Elaine Yuen-Ling Au; Janette Siu-Yin Kwok; Siu-Yuen Chan; Wayland Yuk-Fun Hui; Gilbert T Chua; Jaime Rosa Duque; Kai-Ning Cheong; Patrick Chun Yin Chong; Marco Hok Kung Ho; Tsz-Leung Lee; Wilfred Hing-Sang Wong; Wanling Yang; Pamela P Lee; Wenwei Tu; Xi-Qiang Yang; Yu Lung Lau Journal: Front Immunol Date: 2022-07-08 Impact factor: 8.786